Spots Global Cancer Trial Database for cb7630
Every month we try and update this database with for cb7630 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A QT/QTc and Multi-Dose Pharmacokinetic Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer | NCT00910754 | Prostate Neopla... | Abiraterone ace... Prednisone | 18 Years - | Janssen Research & Development, LLC | |
| A Drug-Drug Interaction Study of Abiraterone Acetate Plus Prednisone With Dextromethorphan and Theophylline in Patients With Metastatic Castration-Resistant Prostate Cancer | NCT01017939 | Prostate Neopla... | Abiraterone ace... Prednisone Dextromethorpha... Theophylline | 18 Years - | Janssen Research & Development, LLC | |
| Abiraterone Acetate in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer | NCT00887198 | Prostate Cancer | Abiraterone ace... Placebo Prednisone | 18 Years - | Janssen Research & Development, LLC | |
| An Observational Study of Continuous Oral Dosing of Abiraterone Acetate in Castration-Resistant Prostate Cancer Patients Evaluating Androgens and Steroid Metabolites in Bone Marrow Plasma | NCT00544440 | Prostate Neopla... | Abiraterone ace... Prednisone | 18 Years - | Janssen Research & Development, LLC | |
| A Drug-Drug Interaction Study of Abiraterone Acetate Plus Prednisone With Dextromethorphan and Theophylline in Patients With Metastatic Castration-Resistant Prostate Cancer | NCT01017939 | Prostate Neopla... | Abiraterone ace... Prednisone Dextromethorpha... Theophylline | 18 Years - | Janssen Research & Development, LLC | |
| An Safety and Efficacy Study of Abiraterone Acetate in Participants With Advanced Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy | NCT00474383 | Prostate Neopla... | Abiraterone ace... Glucocorticoid | 18 Years - | Cougar Biotechnology, Inc. | |
| An Observational Study of Continuous Oral Dosing of Abiraterone Acetate in Castration-Resistant Prostate Cancer Patients Evaluating Androgens and Steroid Metabolites in Bone Marrow Plasma | NCT00544440 | Prostate Neopla... | Abiraterone ace... Prednisone | 18 Years - | Janssen Research & Development, LLC | |
| A QT/QTc and Multi-Dose Pharmacokinetic Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer | NCT00910754 | Prostate Neopla... | Abiraterone ace... Prednisone | 18 Years - | Janssen Research & Development, LLC | |
| A Safety and Efficacy Study of Abiraterone Acetate in Participants With Prostate Cancer Who Have Failed Hormone Therapy | NCT00473512 | Prostatic Neopl... | Abiraterone ace... Abiraterone ace... Dexamethasone | 18 Years - | Cougar Biotechnology, Inc. | |
| An Expanded Access Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer Who Have Completed Clinical Study COU-AA-001 | NCT01664728 | Prostate Neopla... | Abiraterone ace... Glucocorticoid | 18 Years - | Janssen Research & Development, LLC | |
| An Efficacy and Safety Study of Abiraterone Acetate and Prednisone in Participants With Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy | NCT00485303 | Prostatic Neopl... Prostate Cancer | Abiraterone ace... Prednisone | 18 Years - | Cougar Biotechnology, Inc. | |
| Abiraterone Acetate in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer | NCT00887198 | Prostate Cancer | Abiraterone ace... Placebo Prednisone | 18 Years - | Janssen Research & Development, LLC | |
| An Efficacy and Safety Study of Abiraterone Acetate and Prednisone in Participants With Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy | NCT00485303 | Prostatic Neopl... Prostate Cancer | Abiraterone ace... Prednisone | 18 Years - | Cougar Biotechnology, Inc. | |
| A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone Acetate in Male Participants With Prostate Cancer | NCT00924469 | Prostate Cancer | Abiraterone Leuprolide Prednisone | 18 Years - | Janssen Research & Development, LLC |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
